GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » EV-to-EBIT

United Laboratories International Holdings (FRA:UNJ) EV-to-EBIT : 3.87 (As of Apr. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, United Laboratories International Holdings's Enterprise Value is €1,696 Mil. United Laboratories International Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €439 Mil. Therefore, United Laboratories International Holdings's EV-to-EBIT for today is 3.87.

The historical rank and industry rank for United Laboratories International Holdings's EV-to-EBIT or its related term are showing as below:

FRA:UNJ' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.47   Med: 12.22   Max: 142.03
Current: 3.82

During the past 13 years, the highest EV-to-EBIT of United Laboratories International Holdings was 142.03. The lowest was 2.47. And the median was 12.22.

FRA:UNJ's EV-to-EBIT is ranked better than
93.86% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.12 vs FRA:UNJ: 3.82

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. United Laboratories International Holdings's Enterprise Value for the quarter that ended in Jun. 2023 was €927 Mil. United Laboratories International Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €439 Mil. United Laboratories International Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 47.32%.


United Laboratories International Holdings EV-to-EBIT Historical Data

The historical data trend for United Laboratories International Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings EV-to-EBIT Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.10 7.30 3.99 2.73 2.47

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.99 - 2.73 - -

Competitive Comparison of United Laboratories International Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's EV-to-EBIT falls into.



United Laboratories International Holdings EV-to-EBIT Calculation

United Laboratories International Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1696.179/438.829
=3.87

United Laboratories International Holdings's current Enterprise Value is €1,696 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €439 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings  (FRA:UNJ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

United Laboratories International Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=438.829/927.4392
=47.32 %

United Laboratories International Holdings's Enterprise Value for the quarter that ended in Jun. 2023 was €927 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €439 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines